邱露虹, 刘颖娴, 徐希奇. 不容忽视的心肌炎——来自《2021年ESC急慢性心力衰竭诊断与治疗指南》的启示[J]. 协和医学杂志, 2022, 13(4): 530-534. DOI: 10.12290/xhyxzz.2022-0077
引用本文: 邱露虹, 刘颖娴, 徐希奇. 不容忽视的心肌炎——来自《2021年ESC急慢性心力衰竭诊断与治疗指南》的启示[J]. 协和医学杂志, 2022, 13(4): 530-534. DOI: 10.12290/xhyxzz.2022-0077
QIU Luhong, LIU Yingxian, XU Xiqi. Nonnegligible Myocarditis: Insights from 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 530-534. DOI: 10.12290/xhyxzz.2022-0077
Citation: QIU Luhong, LIU Yingxian, XU Xiqi. Nonnegligible Myocarditis: Insights from 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 530-534. DOI: 10.12290/xhyxzz.2022-0077

不容忽视的心肌炎——来自《2021年ESC急慢性心力衰竭诊断与治疗指南》的启示

Nonnegligible Myocarditis: Insights from 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

  • 摘要: 2021年9月,Eur Heart J发布了《2021年ESC急慢性心力衰竭诊断与治疗指南》,该版指南对2016年版指南作出重要更新。其中,心肌炎作为心力衰竭的一种特定临床情况应给予重点关注。本文结合我国心肌炎临床诊疗实践,对新版指南中心肌炎部分进行全面解读,以加深临床医师对此类疾病的认识和理解。

     

    Abstract: In September 2021, Eur Heart J published the 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure, making important updates to the 2016 version. In the new guidelines, myocarditis is identified as a special clinical condition in heart failure that should be given more attention than before. Based on the current clinical practice of myocarditis management in China, this article aims to provide a comprehensive interpretation of the myocarditis section in the new guidelines, with the hope of improving the diagnosis and treatment of this disease.

     

/

返回文章
返回